Access
To read this story in full you will need to login or make a payment (see right).
Correspondence
Nature 458, 281 (19 March 2009) | doi:10.1038/458281c; Published online 18 March 2009
Open Innovation Challenges
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
-
Methods of Modeling Adaptation in Populations
The analysis of adaptation with a population is a frequently encountered computational modeling scen...
nature jobs
Natural Products Chemist
- Praj Matrix - Praj Industries Ltd
- Pune, Maharashtra Pune-411021 India
Academic Dermatopathologist
- Brighsm and Women's Hospital
- Boston, MA
We need more insight into what's worth paying for
William Gunn1
- Genalyte Inc, 11760 Sorrento Valley Road, San Diego, Caifornia 92121, USA
Email: william.gunn@gmail.com
When considering the funding problems causing labs to close (Nature 457, 650–655; 2009), an economic argument can be made that growth depends on the creation of new markets being opened up by new technology. Personalized medicine provides an example of this, as do advances in medical instrumentation such as magnetic resonance imaging and laser eye surgery.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) Registry 1990?1999Bone Marrow Transplantation Original Article
Multilocus heterozygosity and size: a test of hypotheses using triploid Mytilus edulisHeredity Original Article
Backlogged system in Australia shuts out new investigatorsNature Correspondence (19 Mar 2009)
Diversity of funding sources and topics is key to survivalNature Correspondence (19 Mar 2009)
Grant-writing offices would let scientists get on with researchNature Correspondence (19 Mar 2009)

